GTBP - GT Biopharma files for $150M mixed shelf offering
- GT Biopharma ( NASDAQ: GTBP ) has filed for a $150M mixed shelf offering .
- The filing does not necessarily indicate that a sale has begun, or will occur in the future.
- The company intends to use the proceeds for general corporate purposes.
- The offering can include common stock and warrants.
- Seeking Alpha's Quant Rating views GT Biopharma ( GTBP ) as a hold.
For further details see:
GT Biopharma files for $150M mixed shelf offering